U.S. Diversified Financial Stock News

If you are wondering whether Dana's share price still offers value after a strong run, it helps to step back and look at what the current market price might be implying about the business. The stock has pulled back over the last week and month, declining 3.7% over 7 days and 6.5% over 30 days, yet it is still up 37.4% year to date and 108.2% over the past year. Recent coverage around Dana has focused on its role in the Auto Components sector and how investors are reacting to that...

JPMorgan Chase stock in focus JPMorgan Chase (JPM) is back on investors’ radar after recent share price weakness, with the stock down 4.3% over the past month and 0.8% over the past 3 months from its last close of US$300.25. See our latest analysis for JPMorgan Chase. Recent share price momentum has cooled, with the stock down 7.8% year to date, even though the 1 year total shareholder return of 15.2% and very large 3 year total shareholder return of about 13x point to a stronger longer...

For readers wondering whether Fair Isaac, at around US$1,064 per share, is now a bargain or still richly priced, this article walks through what the numbers indicate about the stock's value. The share price has been relatively flat over the last 7 days, edging down 0.2%. It has risen 6.4% over the past month while still sitting well below its levels from earlier in the year, with the stock down 35.2% year to date and 49.9% over the last 12 months. These moves come as investors reassess Fair...

In early May 2026, Tempus AI completed a US$400 million zero-coupon, senior unsecured convertible note offering due 2032 under Rule 144A, shortly after reporting first-quarter revenue of US$348.12 million and a wider net loss of US$125.92 million alongside higher full-year 2026 guidance. At the same time, the company deepened its role in precision medicine through a Lucent Diagnostics collaboration on Alzheimer’s blood-based biomarkers and industry recognition for Ambry Genetics’ CARE...

Mercury Systems (MRCY) has drawn fresh attention after reporting third quarter and nine month results to March 27, 2026, with higher sales and a sharply reduced net loss compared with a year earlier. See our latest analysis for Mercury Systems. The latest results appear to have reinforced a recovery story in the stock, with a 30 day share price return of 12.09% and a 1 year total shareholder return of 106.11%, suggesting momentum has been building over time. If these results have you looking...

Valero Energy Corporation recently reported first-quarter 2026 results, with sales of US$30,656 million and net income of US$1,263 million, and its board declared a regular quarterly cash dividend of US$1.20 per share payable on June 23, 2026 to shareholders of record on May 21, 2026. These results mark a shift from a net loss in the prior-year quarter while the maintained dividend and director stock unit awards highlight management’s emphasis on consistent capital returns and governance...

CME Group and Silicon Data have already announced plans to launch a first-in-class compute futures market later in 2026, pending regulatory review, using Silicon Data’s daily GPU rental-rate indices to bring standardized pricing and risk management to the multi-trillion-dollar compute market. This move effectively treats computing power as a tradable asset class, potentially reshaping how AI builders, cloud providers and financial institutions plan and hedge long-term infrastructure...

If you are wondering whether Jabil's current share price offers value or is getting ahead of itself, the recent performance gives plenty to think about. The stock closed at US$355.43, with the price falling 4.5% over the last week but rising 16.4% over the past month, 47.9% year to date and 113.3% over the last year, while the three year and five year returns are very large. Recent news around Jabil has focused on providing ongoing coverage of the stock for investors, keeping attention on...

PayPal Holdings (NasdaqGS:PYPL) agreed to a US$30 million settlement with the US Department of Justice related to its diversity, equity and inclusion practices. As part of the resolution, PayPal plans to waive certain fees for eligible small businesses and has announced a new Small Business Initiative. The initiative includes revised eligibility criteria that are intended to address regulatory feedback on how DEI-linked programs are structured. For investors watching payments and fintech,...

Prelude Therapeutics (PRLD) opened Q1 2026 with revenue of US$4.6 million and a net loss of US$10.4 million, translating to a basic EPS loss of US$0.13 as the company continued to invest heavily in its pipeline. Over recent quarters, the company has seen revenue move from US$0 in Q1 2025 to US$6.5 million in Q3 2025 and US$5.6 million in Q4 2025 before landing at US$4.6 million in Q1 2026. Quarterly net losses shifted from US$32.1 million in Q1 2025 to US$10.4 million in the latest period,...

AECOM's Q2 2026 earnings snapshot AECOM (ACM) has released its Q2 2026 results, reporting revenue of US$3.8 billion and basic EPS of US$1.43, alongside trailing 12 month net income from continuing operations of US$631.3 million. Over recent quarters, the company has seen quarterly revenue move between US$3.8 billion and US$4.2 billion, while basic EPS has ranged from US$0.99 to US$1.43, giving investors a clear read on how earnings track against a trailing 12 month EPS of US$4.82. With a...

Kura Oncology (KURA) opened Q1 2026 with revenue of US$18.3 million and a basic EPS loss of US$0.83, while trailing 12 month figures show revenue of US$71.6 million and a basic EPS loss of US$3.35. Over recent quarters, the company has seen quarterly revenue move between US$14.1 million and US$20.8 million, with basic EPS losses in a range from US$0.66 to US$0.92. Investors are likely to weigh this latest print against expectations for faster top line growth relative to ongoing pressure on...

Janus International Group (JBI) has reported Q1 2026 revenue of US$222.7 million with basic EPS of about US$0.00, alongside trailing twelve month revenue of US$896.4 million and EPS of US$0.31, against a backdrop of trailing net profit margin at 4.8% compared with 5.4% a year earlier. Over the past year, revenue has moved from US$963.8 million to US$896.4 million on a trailing basis as EPS shifted from US$0.49 to US$0.31. Investors are weighing forecast earnings growth of about 15.1% a year...

Xcel Energy (XEL) is in focus after reporting first quarter 2026 earnings, reaffirming its full year EPS guidance of $4.04 to $4.16 and signing a new Google data center power agreement. See our latest analysis for Xcel Energy. Recent news, including the Google data center agreement, Q1 2026 earnings and a planned US$4.3b follow on equity offering, comes as Xcel Energy’s share price return has gained 7% year to date. The 1 year total shareholder return sits at 19.82% and the 3 year total...

C4 Therapeutics (CCCC) has opened 2026 with Q1 revenue of US$6.2 million and a basic EPS loss of US$0.20, alongside a trailing twelve month revenue base of US$34.9 million and a net loss of US$103.8 million, setting a clear tone for how the market will read the latest update. Over recent quarters the company has seen revenue move between US$5.2 million in Q4 2024 and US$11.2 million in Q3 2025, while quarterly basic EPS has ranged from a loss of US$0.18 to a loss of US$0.49. This print keeps...

Enovix recently appointed veteran semiconductor sales executive Steve Bakos as Senior Vice President of Worldwide Sales, as the company moves from technology qualification toward commercial execution of its 100% silicon-anode and silicon‑enhanced batteries across consumer and industrial markets. This hire, combined with closer alignment on a silicon‑specific qualification framework with a lead smartphone customer, signals Enovix is building the commercial infrastructure required to support...

South Korea has agreed to invest in NuScale Power's small modular reactor program, with plans for an initial SMR plant in the Uljin region. Korean companies including Doosan Enerbility and Samsung C&T are involved in the collaboration, tying NuScale into South Korea's wider nuclear supply chain. NuScale is also expanding its industrial and European presence through partnerships with Framatome and Ebara Elliott Energy. NuScale Power (NYSE:SMR) is drawing fresh attention as South Korea backs...

Earnings beat and partnerships put Hertz Global Holdings (HTZ) in focus Hertz Global Holdings (HTZ) is back on investors’ radar after first quarter earnings revenue came in ahead of expectations, paired with reduced net losses and a cluster of new partnership announcements. For the quarter ended March 31, 2026, Hertz reported sales of US$2,004 million compared with US$1,813 million a year earlier. The company recorded a net loss of US$333 million, narrower than the US$443 million loss in the...

Energy Vault Holdings (NRGV) is back in focus after announcing an agreement with Eskom to roll out long duration gravity energy storage systems across Southern Africa, alongside recent earnings and guidance updates. See our latest analysis for Energy Vault Holdings. The Eskom agreement and reaffirmed 2026 revenue guidance have arrived alongside sharp share price momentum, with a 90 day share price return of 90.38% and a very large 1 year total shareholder return, although the 5 year total...

Evolution Petroleum (EPM) has just posted a soft Q3 2026, with total revenue of US$20.2 million and a basic EPS loss of US$0.26 alongside a net loss of US$8.9 million, setting a cautious tone for the quarter. The company has seen quarterly revenue move in a tight band between US$20.2 million and US$22.6 million over the past six reported periods, while EPS has swung between a profit of US$0.10 and a loss of US$0.26, leaving investors focused on how consistently the business can translate its...

Stereotaxis (STXS) opened Q1 2026 with revenue of US$6.3 million and a net loss of US$6.2 million, equal to an EPS loss of US$0.06, as the stock trades around US$1.85. The company reported quarterly revenue of US$7.5 million in Q1 2025 and US$6.3 million in Q1 2026, while EPS loss moved from US$0.07 to US$0.06 over the same period. On a trailing twelve month basis, EPS loss was US$0.24 on revenue of US$31.2 million. Overall, the update keeps the focus on how revenue growth potential might...

OptimizeRx (NasdaqCM:OPRX) opened 2026 with Q1 revenue of US$19.8 million and a reported loss of US$0.5 million, or EPS of US$0.03, setting a more muted tone after a profitable 2025. The company has seen quarterly revenue move from US$21.9 million in Q1 2025 to US$19.8 million in Q1 2026. EPS shifted from a loss of US$0.12 to a smaller loss of US$0.03 as trailing 12 month EPS reached US$0.37. With margins now positive on a trailing 12 month basis and near break even in the latest quarter, the...

Optum Rx, the pharmacy benefit arm of UnitedHealth Group (NYSE:UNH), plans to launch a transparent, fee-based PBM model in 2027. The model shifts away from list price and volume based reimbursement toward per member fees, removes spread pricing, and adds digital tools for clearer drug cost information. The change follows growing regulatory scrutiny of PBMs and is positioned to alter how employers, health plans and members interact with prescription benefits. For investors watching NYSE:UNH,...

Caterpillar (CAT) has been in focus after its first quarter 2026 report showed revenue of US$17,415 million and net income of US$2,549 million, alongside management raising full year sales guidance. See our latest analysis for Caterpillar. Caterpillar’s share price has eased in the very short term, with a 1-day share price return of 1.08% down and a 7-day return of 2.66% down. However, momentum over longer periods remains strong, including a 30-day share price return of 13.97% and a...